Literature DB >> 3951461

The effect of gossypol on the frequency of DNA-strand breaks in human leukocytes in vitro.

Y Chen, M Sten, M Nordenskjöld, B Lambert, S A Matlin, R H Zhou.   

Abstract

Gossypol, a human antifertility agent isolated from the cotton plant, was found to induce a dose-dependent increase in the frequency of DNA-strand breaks in human leukocytes exposed to 2-40 micrograms/ml of the drug for 1 h in serum-free medium in vitro. DNA-strand breaks were studied by alkaline elution or alkaline unwinding of DNA followed by hydroxylapatite-chromatography. No decrease of gossypol-induced DNA-strand breaks was observed after post-treatment incubation times up to 24 h, whereas X-ray-induced DNA breaks disappeared within 2 h under the same incubation conditions. Cells exposed to gossypol in the presence of 10% fetal calf serum showed no or little increase of DNA breaks, suggesting that serum proteins inhibit the DNA-damaging activity of the drug. Both optical isomers of gossypol induced DNA-strand breaks. However, the effect of (-)-gossypol was only about half of that of (+)-gossypol and the racemic form. The induction and persistence of DNA-strand breaks by gossypol, as well as the reduction of this effect in the presence of serum should be considered in the evaluation of the potential in vivo genotoxicity of the drug.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951461     DOI: 10.1016/0165-1161(86)90043-9

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  2 in total

1.  Comparison of the efficacy of gossypol acetate enantiomers in rats with uterine leiomyoma.

Authors:  Jie Yuan; Mengyu Zhou; Xiaobing Xin; Jun Yao; Junmin Chang
Journal:  J Nat Med       Date:  2022-08-19       Impact factor: 3.192

2.  Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi.

Authors:  R Kaminsky; E Zweygarth
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.